5-HT3 receptor antagonists ameliorate fatigue: So much potential, so little knowledge!

Abstract

There is growing evidence that 5-HT3 receptor blockade will benefit patients with fatigue. Further research is needed to determine the mechanism underlying this widespread clinically important symptom and therapies may be derived from targeting the 5-HT system.